Showing posts with label TTUHSC. Show all posts
Showing posts with label TTUHSC. Show all posts

Monday, August 18, 2014

Weekly Edition, Issue 64

The Weekly Edition, Issue 64 has arrived! Take a look at the newest issue of our Weekly Edition, by clicking HERE. (Note: The newsletter will open in PDF format.)

In this edition:

Don't forget to sign up to be notified when each week's new issue is available. Subscribe below.

Subscribe to our mailing list
* indicates required

Tuesday, October 15, 2013

Medical Center of the Americas Growth

Foundation to Present 1st Annual Impact Fund Report

The City of El Paso will get the first annual report from the Medical Center of the Americas (MCA) Foundation this week on various ongoing efforts bolstered by the City’s investment last year. A Chapter 380 Economic Development Program Grant Agreement was established on February 7, 2012 between the City and the MCA Foundation.
This rendering shows what the entrance to the Cardwell Collaborative Building may look like when it opens in August 2015. (www.elpasotexas.gov)
Representatives of the MCA will update City officials on various endeavors including funding resources, staffing efforts, and planning and design details for a biomedical institute and the tech park. The Foundation is also working continuously to acquire properties in the vicinity of the MCA campus.
The Cardwell Collaborative Building will be visible from Interstate 10. (mcamericas.org)
The Biomedical Institute of the Americas (BMIA) was formed last year with help of City grant funding to encourage biomedical research and innovation in the El Paso region. To date, the BMIA has “triaged” biomed companies on a local and national level, according to the report, and hopes to become a “robust innovation pipeline” within five years.
A Cafe will be located on the first floor of the Cardwell Collaborative.
Another venture the MCA Foundation has undertaken is the Clinical Research Organization (CRO), an effort to launch a local clinical trials network. The Foundation will align itself with one or more CROs, identify products needing clinical trials, and integrate them into the local provider network. The CRO launched in 2012.